197 related articles for article (PubMed ID: 21131601)
21. Epidermal growth factor inhibits transforming growth factor-β-induced fibrogenic differentiation marker expression through ERK activation.
Liu X; Hubchak SC; Browne JA; Schnaper HW
Cell Signal; 2014 Oct; 26(10):2276-83. PubMed ID: 24905473
[TBL] [Abstract][Full Text] [Related]
22. TbetaRI/Alk5-independent TbetaRII signaling to ERK1/2 in human skin cells according to distinct levels of TbetaRII expression.
Bandyopadhyay B; Han A; Dai J; Fan J; Li Y; Chen M; Woodley DT; Li W
J Cell Sci; 2011 Jan; 124(Pt 1):19-24. PubMed ID: 21172820
[TBL] [Abstract][Full Text] [Related]
23. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
Guo Y; Kyprianou N
Cancer Res; 1999 Mar; 59(6):1366-71. PubMed ID: 10096572
[TBL] [Abstract][Full Text] [Related]
24. SPSB1, a Novel Negative Regulator of the Transforming Growth Factor-β Signaling Pathway Targeting the Type II Receptor.
Liu S; Nheu T; Luwor R; Nicholson SE; Zhu HJ
J Biol Chem; 2015 Jul; 290(29):17894-17908. PubMed ID: 26032413
[TBL] [Abstract][Full Text] [Related]
25. Transforming growth factor beta 1 stimulates expression of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA by an indirect mechanism which requires the MAPK kinase pathway.
Fahmi H; Cochet C; Hmama Z; Opolon P; Joab I
J Virol; 2000 Jul; 74(13):5810-8. PubMed ID: 10846060
[TBL] [Abstract][Full Text] [Related]
26. Growth inhibition induced by transforming growth factor-beta1 in human oral squamous cell carcinoma.
Wang X; Sun W; Bai J; Ma L; Yu Y; Geng J; Qi J; Shi Z; Fu S
Mol Biol Rep; 2009 May; 36(5):861-9. PubMed ID: 18418730
[TBL] [Abstract][Full Text] [Related]
27. Extracellular and cytoplasmic domains of endoglin interact with the transforming growth factor-beta receptors I and II.
Guerrero-Esteo M; Sanchez-Elsner T; Letamendia A; Bernabeu C
J Biol Chem; 2002 Aug; 277(32):29197-209. PubMed ID: 12015308
[TBL] [Abstract][Full Text] [Related]
28. Disruption of transforming growth factor beta signaling by a novel ligand-dependent mechanism.
Fernandez T; Amoroso S; Sharpe S; Jones GM; Bliskovski V; Kovalchuk A; Wakefield LM; Kim SJ; Potter M; Letterio JJ
J Exp Med; 2002 May; 195(10):1247-55. PubMed ID: 12021305
[TBL] [Abstract][Full Text] [Related]
29. The core-aldehyde 9-oxononanoyl cholesterol increases the level of transforming growth factor beta1-specific receptors on promonocytic U937 cell membranes.
Gargiulo S; Gamba P; Sottero B; Biasi F; Chiarpotto E; Serviddio G; Vendemiale G; Poli G; Leonarduzzi G
Aging Cell; 2009 Apr; 8(2):77-87. PubMed ID: 19302374
[TBL] [Abstract][Full Text] [Related]
30. Resistance to TGF-beta 1 correlates with aberrant expression of TGF-beta receptor II in human B-cell lymphoma cell lines.
Chen G; Ghosh P; Osawa H; Sasaki CY; Rezanka L; Yang J; O'Farrell TJ; Longo DL
Blood; 2007 Jun; 109(12):5301-7. PubMed ID: 17339425
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of HER2 (erbB2) in human breast epithelial cells unmasks transforming growth factor beta-induced cell motility.
Ueda Y; Wang S; Dumont N; Yi JY; Koh Y; Arteaga CL
J Biol Chem; 2004 Jun; 279(23):24505-13. PubMed ID: 15044465
[TBL] [Abstract][Full Text] [Related]
32. In the absence of type III receptor, the transforming growth factor (TGF)-beta type II-B receptor requires the type I receptor to bind TGF-beta2.
del Re E; Babitt JL; Pirani A; Schneyer AL; Lin HY
J Biol Chem; 2004 May; 279(21):22765-72. PubMed ID: 14996829
[TBL] [Abstract][Full Text] [Related]
33. Controlling long-term signaling: receptor dynamics determine attenuation and refractory behavior of the TGF-β pathway.
Vizán P; Miller DS; Gori I; Das D; Schmierer B; Hill CS
Sci Signal; 2013 Dec; 6(305):ra106. PubMed ID: 24327760
[TBL] [Abstract][Full Text] [Related]
34. Menin expression is regulated by transforming growth factor beta signaling in leukemia cells.
Zhang H; Liu ZG; Hua XX
Chin Med J (Engl); 2011 May; 124(10):1556-62. PubMed ID: 21740816
[TBL] [Abstract][Full Text] [Related]
35. TLR4 ligand/H₂O₂ enhances TGF-β1 signaling to induce metastatic potential of non-invasive breast cancer cells by activating non-Smad pathways.
Zhou YH; Liao SJ; Li D; Luo J; Wei JJ; Yan B; Sun R; Shu Y; Wang Q; Zhang GM; Feng ZH
PLoS One; 2013; 8(5):e65906. PubMed ID: 23734265
[TBL] [Abstract][Full Text] [Related]
36. Solar ultraviolet irradiation reduces collagen in photoaged human skin by blocking transforming growth factor-beta type II receptor/Smad signaling.
Quan T; He T; Kang S; Voorhees JJ; Fisher GJ
Am J Pathol; 2004 Sep; 165(3):741-51. PubMed ID: 15331399
[TBL] [Abstract][Full Text] [Related]
37. Ternary complex of transforming growth factor-beta1 reveals isoform-specific ligand recognition and receptor recruitment in the superfamily.
Radaev S; Zou Z; Huang T; Lafer EM; Hinck AP; Sun PD
J Biol Chem; 2010 May; 285(19):14806-14. PubMed ID: 20207738
[TBL] [Abstract][Full Text] [Related]
38. Restoration of TGF-beta signalling reduces tumorigenicity in human lung cancer cells.
Anumanthan G; Halder SK; Osada H; Takahashi T; Massion PP; Carbone DP; Datta PK
Br J Cancer; 2005 Nov; 93(10):1157-67. PubMed ID: 16251876
[TBL] [Abstract][Full Text] [Related]
39. Pluripotency gene expression and growth control in cultures of peripheral blood monocytes during their conversion into programmable cells of monocytic origin (PCMO): evidence for a regulatory role of autocrine activin and TGF-β.
Ungefroren H; Hyder A; Hinz H; Groth S; Lange H; El-Sayed KM; Ehnert S; Nüssler AK; Fändrich F; Gieseler F
PLoS One; 2015; 10(2):e0118097. PubMed ID: 25707005
[TBL] [Abstract][Full Text] [Related]
40. IQGAP1 suppresses TβRII-mediated myofibroblastic activation and metastatic growth in liver.
Liu C; Billadeau DD; Abdelhakim H; Leof E; Kaibuchi K; Bernabeu C; Bloom GS; Yang L; Boardman L; Shah VH; Kang N
J Clin Invest; 2013 Mar; 123(3):1138-56. PubMed ID: 23454766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]